Wilmington Savings Fund Society’s Regeneron Pharmaceuticals REGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $381K | Sell |
726
-505
| -41% | -$265K | 0.01% | 647 |
|
|
2025
Q1 | $781K | Sell |
1,231
-464
| -27% | -$294K | 0.01% | 465 |
|
|
2024
Q4 | $1.21M | Sell |
1,695
-115
| -6% | -$81.9K | 0.02% | 394 |
|
|
2024
Q3 | $1.9M | Buy |
1,810
+1,193
| +193% | +$1.25M | 0.03% | 322 |
|
|
2024
Q2 | $648K | Sell |
617
-10
| -2% | -$10.5K | 0.02% | 237 |
|
|
2024
Q1 | $603K | Buy |
+627
| New | +$603K | 0.02% | 245 |
|
|
2023
Q3 | $523K | Sell |
635
-26
| -4% | -$21.4K | 0.02% | 252 |
|
|
2023
Q2 | $475K | Hold |
661
| – | – | 0.02% | 269 |
|
|
2023
Q1 | $543K | Buy |
661
+9
| +1% | +$7.39K | 0.02% | 245 |
|
|
2022
Q4 | $470K | Hold |
652
| – | – | 0.02% | 256 |
|
|
2022
Q3 | $449K | Hold |
652
| – | – | 0.02% | 256 |
|
|
2022
Q2 | $385K | Hold |
652
| – | – | 0.02% | 278 |
|
|
2022
Q1 | $455K | Hold |
652
| – | – | 0.02% | 278 |
|
|
2021
Q4 | $412K | Hold |
652
| – | – | 0.01% | 298 |
|
|
2021
Q3 | $395K | Hold |
652
| – | – | 0.02% | 299 |
|
|
2021
Q2 | $364K | Sell |
652
-4
| -0.6% | -$2.23K | 0.01% | 313 |
|
|
2021
Q1 | $310K | Sell |
656
-407
| -38% | -$192K | 0.01% | 320 |
|
|
2020
Q4 | $514K | Buy |
+1,063
| New | +$514K | 0.02% | 274 |
|